These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 10930805

  • 1. Modulation of drug resistance by alpha-tubulin in paclitaxel-resistant human lung cancer cell lines.
    Han EK, Gehrke L, Tahir SK, Credo RB, Cherian SP, Sham H, Rosenberg SH, Ng S.
    Eur J Cancer; 2000 Aug; 36(12):1565-71. PubMed ID: 10930805
    [Abstract] [Full Text] [Related]

  • 2. Modulation of paclitaxel resistance by annexin IV in human cancer cell lines.
    Han EK, Tahir SK, Cherian SP, Collins N, Ng SC.
    Br J Cancer; 2000 Jul; 83(1):83-8. PubMed ID: 10883672
    [Abstract] [Full Text] [Related]

  • 3. Combretastatin A-4 resistance in H460 human lung carcinoma demonstrates distinctive alterations in beta-tubulin isotype expression.
    Wehbe H, Kearney CM, Pinney KG.
    Anticancer Res; 2005 Jul; 25(6B):3865-70. PubMed ID: 16309172
    [Abstract] [Full Text] [Related]

  • 4. Characterization of a taxol-resistant human small-cell lung cancer cell line.
    Ohta S, Nishio K, Kubota N, Ohmori T, Funayama Y, Ohira T, Nakajima H, Adachi M, Saijo N.
    Jpn J Cancer Res; 1994 Mar; 85(3):290-7. PubMed ID: 7514586
    [Abstract] [Full Text] [Related]

  • 5. Non-adherent culture induces paclitaxel resistance in H460 lung cancer cells via ERK-mediated up-regulation of βIVa-tubulin.
    Atjanasuppat K, Lirdprapamongkol K, Jantaree P, Svasti J.
    Biochem Biophys Res Commun; 2015 Oct 23; 466(3):493-8. PubMed ID: 26375501
    [Abstract] [Full Text] [Related]

  • 6. Establishment and characterization of a paclitaxel-resistant human non-small cell lung cancer cell line.
    Chu JJ, Chiang CD, Rao CS, Chang WM, Lai YK.
    Anticancer Res; 2000 Oct 23; 20(4):2449-56. PubMed ID: 10953309
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of IL-6 but not IL-8 increases paclitaxel resistance of U-2OS human osteosarcoma cells.
    Duan Z, Lamendola DE, Penson RT, Kronish KM, Seiden MV.
    Cytokine; 2002 Mar 07; 17(5):234-42. PubMed ID: 12027404
    [Abstract] [Full Text] [Related]

  • 8. Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in alpha-tubulin.
    Loganzo F, Hari M, Annable T, Tan X, Morilla DB, Musto S, Zask A, Kaplan J, Minnick AA, May MK, Ayral-Kaloustian S, Poruchynsky MS, Fojo T, Greenberger LM.
    Mol Cancer Ther; 2004 Oct 07; 3(10):1319-27. PubMed ID: 15486199
    [Abstract] [Full Text] [Related]

  • 9. Gene amplification and expression in lung cancer cells with acquired paclitaxel resistance.
    Yabuki N, Sakata K, Yamasaki T, Terashima H, Mio T, Miyazaki Y, Fujii T, Kitada K.
    Cancer Genet Cytogenet; 2007 Feb 07; 173(1):1-9. PubMed ID: 17284363
    [Abstract] [Full Text] [Related]

  • 10. Altered beta-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells.
    Ranganathan S, Benetatos CA, Colarusso PJ, Dexter DW, Hudes GR.
    Br J Cancer; 1998 Feb 07; 77(4):562-6. PubMed ID: 9484812
    [Abstract] [Full Text] [Related]

  • 11. Drug resistance to paclitaxel is not only associated with ABCB1 mRNA expression but also with drug accumulation in intracellular compartments in human lung cancer cell lines.
    Shimomura M, Yaoi T, Itoh K, Kato D, Terauchi K, Shimada J, Fushiki S.
    Int J Oncol; 2012 Apr 07; 40(4):995-1004. PubMed ID: 22179563
    [Abstract] [Full Text] [Related]

  • 12. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
    Kumar A, Soprano DR, Parekh HK.
    Cancer Res; 2001 Oct 15; 61(20):7552-5. PubMed ID: 11606393
    [Abstract] [Full Text] [Related]

  • 13. Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of beta-tubulin (Asp26Glu) and less stable microtubules.
    Hari M, Loganzo F, Annable T, Tan X, Musto S, Morilla DB, Nettles JH, Snyder JP, Greenberger LM.
    Mol Cancer Ther; 2006 Feb 15; 5(2):270-8. PubMed ID: 16505100
    [Abstract] [Full Text] [Related]

  • 14. Antisense oligonucleotides to class III beta-tubulin sensitize drug-resistant cells to Taxol.
    Kavallaris M, Burkhart CA, Horwitz SB.
    Br J Cancer; 1999 Jun 15; 80(7):1020-5. PubMed ID: 10362110
    [Abstract] [Full Text] [Related]

  • 15. Activity of docetaxel in paclitaxel-resistant ovarian cancer cells.
    Sato S, Kigawa J, Kanamori Y, Itamochi H, Oishi T, Shimada M, Iba T, Naniwa J, Uegaki K, Terakawa N.
    Cancer Chemother Pharmacol; 2004 Mar 15; 53(3):247-52. PubMed ID: 14610615
    [Abstract] [Full Text] [Related]

  • 16. Acquisition of taxol resistance via P-glycoprotein- and non-P-glycoprotein-mediated mechanisms in human ovarian carcinoma cells.
    Parekh H, Wiesen K, Simpkins H.
    Biochem Pharmacol; 1997 Feb 21; 53(4):461-70. PubMed ID: 9105396
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells.
    Duan Z, Brakora KA, Seiden MV.
    Mol Cancer Ther; 2004 Jul 21; 3(7):833-8. PubMed ID: 15252144
    [Abstract] [Full Text] [Related]

  • 18. Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization.
    Giannakakou P, Sackett DL, Kang YK, Zhan Z, Buters JT, Fojo T, Poruchynsky MS.
    J Biol Chem; 1997 Jul 04; 272(27):17118-25. PubMed ID: 9202030
    [Abstract] [Full Text] [Related]

  • 19. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line.
    Wang NN, Zhao LJ, Wu LN, He MF, Qu JW, Zhao YB, Zhao WZ, Li JS, Wang JH.
    Asian Pac J Cancer Prev; 2013 Jul 04; 14(9):4983-8. PubMed ID: 24175763
    [Abstract] [Full Text] [Related]

  • 20. Taxol Analogues Exhibit Differential Effects on Photoaffinity Labeling of β-Tubulin and the Multidrug Resistance Associated P-Glycoprotein.
    Yang CH, Wang C, Ojima I, Horwitz SB.
    J Nat Prod; 2018 Mar 23; 81(3):600-606. PubMed ID: 29517223
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.